20
Hetero Drugs Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Rizatriptan benzoate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2013-235 - Rev 00
This Chemical Type CEP, issued on May 31, 2016, remains in force until September 08, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 2585 associated with this CEP further emphasizes